🦠
SARS-CoV-2
13 articles analyzed — Average score : 40/100
Grade distribution
Authors' conclusions
Articles
B
Mostly reliable (66/100)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Positive
RECOVERY Collaborative Group & RECOVERY Collaborative Group·Lancet (London, England)·May 2021
B
Mostly reliable (64/100)
Effect of Early Treatment with Ivermectin among Patients with Covid-19. Negative
Reis G et al.·New England Journal of Medicine·Mar 2022
B
Mostly reliable (62/100)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. Positive
Voysey M et al.·Lancet·Jan 2021
B
Mostly reliable (60/100)
Physical interventions to interrupt or reduce the spread of respiratory viruses. Negative
Jefferson T et al.·The Cochrane database of systematic reviews·Jan 2023
B
Mostly reliable (56/100)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. Positive
Jayk Bernal A et al.·New England Journal of Medicine·Mar 2022
C
Nuanced (48/100)
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Mixed
Lopez Bernal J et al.·The New England journal of medicine·Jul 2021
C
Nuanced (46/100)
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. Positive
Charmet T et al.·Lancet Regional Health – Europe·Jul 2021
D
Unreliable (39/100)
SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021. Positive
Fournier PE et al.·Frontiers in Microbiology·Jan 2022
E
Not reliable (25/100)
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Positive
Bryant A et al.·American Journal of Therapeutics·Jun 2021
E
Not reliable (24/100)
Molecular mimicry between SARS-CoV-2 and the female reproductive system. Positive
Dotan A et al.·Am J Reprod Immunol·Jan 2021
E
Not reliable (24/100)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Positive
Khoury DS et al.·Nature medicine·May 2021
X
Invalidated (0/100)
Retracted
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. Negative
Mehra MR et al.·The New England Journal of Medicine·May 2020
X
Invalidated (0/100)
Retracted
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Positive
Mehra MR et al.·The Lancet·May 2020